Corporate Offices

Capabilities Overview

Patheon Inc. (TSX: PTI; www.patheon.com) is a leading global provider of contract development and manufacturing services to the pharmaceutical industry. Patheon prides itself in providing the highest quality products and services to more than 300 pharmaceutical and biotechnology companies. Patheon's services range from preclinical development through the commercial manufacturing of a wide array of dosage forms including parenteral, solid, semi-solid and liquids.

Patheon's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical supplies, scale-up and commercialization. Patheon's ability to integrate development and manufacturing services ensures that our customers' projects are delivered on time and meet the high standards of quality that Patheon is known for.

Patheon's integrated development and manufacturing network of 10 facilities and 7 development centers, across North America and Europe, strives to ensure that customer products can be launched timely and confidently anywhere in the world.

Commercial Manufacturing Services

Patheon's commercial manufacturing dosage capabilities:

• Solids in tablets, capsules, and powders
• Liquids & Semi-Solids Capabilities
• Sterile Products Capabilities
• Lyophilization Capabilities
• High Potency Capabilities
• Controlled Substances Capabilities
• Cephalosporin Capabilities & Lyophilization
• Solutions, suspensions, sprays and gels
• Liquid Filled Hard Capsules
• Cytotoxics

Commercial Manufacturing for Specialized Services

• Quick to Market™
• Restructuring Services
• Small Scale Commercial Manufacturing

Pharmaceutical Development Services

• Pre-formulation
• Analytical Methods
• Scale up & Validation
• Biopharmaceutical
• Product Registration
• Tech Transfer

Specialized Development Services

• Unique Dosage Forms
• Quick to Clinic™
• Strategic Alliances
• Clinical Supplies

Please click here to see an enlarged version of the matrix in PDF format.

Clinical Supplies

• Primary and secondary clinical supplies packaging
• Blinded & multi-language labeling
• Storage
• Global distribution
• Returns
• Reconciliation and destruction

Enhanced services provided by Patheon:

QUICK TO CLINIC™

Patheon offers Quick to Clinic™ programs focused on bringing new molecules to FTIH studies as rapidly as possible while minimizing the amount of API required. Patheon uses the experience and scientific knowledge of its team of Pharmaceutical Development Services (PDS) scientists combined with a number of tools and strategies to achieve these results.

Quick to Clinic™ Dosage Forms:

• Blend in capsule
• API in capsule
• Blend in bottle
• API in bottle
• Tablets
• Oral solutions

Why use Patheon's Quick to Clinic™ service?

• Fast, Flexible, Proven
• Delivery in 4 Months
• Specialized early phase development centers
• Global Network
• No scheduling competition with late phase projects
• Simple, fit for purpose formulations
• Blend in capsule
• API in capsule
• Blend in bottle
• API in bottle
• Tablets
• Oral solutions

The ‘4•6•8 Promise™'

The Quick To Market™ program also introduces its ‘4•6•8 Promise™'. The term is used to highlight the benefits of its rapid development / rapid transfer programs by emphasizing to clients how quickly the work can be done by Patheon while maintaining the high standards of quality that Patheon is known for. The ‘4•6•8 Promise™', as it is now called, is more adequately described as follows:

• 4: Quick To Clinic™ solid dose molecules will be formulated and ready for distribution to phase 1 clinical trials in just four months from receipt of API.

• 6: Quick To Market™ solid dose or liquid products will be transferred and ready for regulatory filing in just six months from receipt of analytical methods and API. This enables clients to move products very quickly out of their plants and facilitate rationalization programs.
• 8: Quick To Market™ aseptic liquid or lyophilized sterile products will be ready for regulatory filing in just eight months from receipt of analytical methods and API.

Click Here To Download:
•Datasheet: Quick To Clinic™
•Datasheet: Quick to Market™
•Datasheet: 4.6.8 Promise™
•Datasheet: Early Formulation Development
•Datasheet: Pharmaceutical Analytical Development
•Datasheet: Clinical Supplies Services
•Datasheet: Business Management
•Datasheet: Oral Dose Contract Manufacturing
•Datasheet: Pharmaceutical Drug Delivery
•Datasheet: Sterile Contract Manufacturing
•Datasheet: Biopharmaceutical Contract Manufacturing
•Datasheet: High Potency Contract Manufacturing
•Datasheet: Pediatric Formulation Development
•Datasheet: Clinical Supplies Services
•Datasheet: Cephalosporin Contract Manufacturing
•Datasheet: Puerto Rico Facility
•Datasheet: Small Scale Commercial Manufacturing
•Datasheet: Low Solubility Compounds
•Datasheet: Cytotoxic Contract Manufacturing
•Datasheet: Lean 6 Sigma
•Datasheet: Roller Compaction